Teleflex Selected to Exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at Vizient Innovative Technology Exchange
15 Setembro 2023 - 7:30AM
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies, today announced it has been selected to
exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded
with the NaviCurve™ Stylet at the Vizient Innovative Technology
Exchange. Vizient, Inc., the nation’s largest provider-driven
healthcare performance improvement company, will hold the Exchange
on Oct. 3 in Grapevine, Texas.
The annual Innovative Technology Exchange offers selected
suppliers the unique opportunity to demonstrate their product or
service to supply chain and clinical leaders from Vizient’s
provider customers and subject matter experts who serve on their
supply councils. Each product or service will showcase how it
improves clinical outcomes, enhances safety or drives incremental
improvements to healthcare delivery or business models.
The VPS Rhythm™ DLX Device and NaviCurve™ Stylet are engineered
to work together to give Vascular Access Specialists more efficient
and predictable PICC placement.
The next-generation VPS Rhythm™ DLX Device provides real-time
catheter tip location information by using the patient’s cardiac
electrical activity. The device is also available with an optional
integrated ultrasound featuring a Catheter-to-Vessel ratio tool
that promotes standardization in vessel measurement. This device
works in concert with the Arrow™ PICC preloaded with the NaviCurve™
Stylet, providing innovative tip navigation/location
technologies.
The VPS Rhythm™ DLX Device eliminates the need for a
confirmatory x-ray, helping the clinician insert seamlessly through
ultrasound vessel assessment, PICC navigation, to final tip
confirmation in the lower third of the superior vena cava.1
Due to the variability of patient vasculature, all PICCs can
occasionally have difficulty advancing into the superior vena cava
(SVC) on the first attempt. The NaviCurve™ Stylet features an
anatomical curve and flexible tip that are designed to self-orient
to patient anatomy for enhanced PICC advancement into the superior
vena cava (SVC) for successful insertion.1
“We are very excited to bring our PICCs and Navigation system to
the Vizient Innovative Technology Exchange,” says Lisa Kudlacz,
President and General Manager, Vascular at Teleflex. “Partnering
with healthcare providers to eliminate vascular access related
complications is important work, and we are eager to show off the
VPS Rhythm™ DLX Device and updated Arrow™ PICCs preloaded with the
NaviCurve™ Stylet to demonstrate exactly how it can help enhance
care.”
The annual Innovative Technology Exchange is part of Vizient’s
Innovative Technology Program that includes product review of
supplier-submitted technologies by provider-led councils and task
forces. Since 2003, Vizient has reviewed over 1,600 product
submissions as part of its Innovative Technology Program.
About Teleflex IncorporatedTeleflex is a global
provider of medical technologies designed to improve the health and
quality of people’s lives. We apply purpose driven innovation – a
relentless pursuit of identifying unmet clinical needs – to benefit
patients and healthcare providers. Our portfolio is diverse, with
solutions in the fields of vascular access, interventional
cardiology and radiology, anesthesia, emergency medicine, surgical,
urology and respiratory care. Teleflex employees worldwide are
united in the understanding that what we do every day makes a
difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow™, Deknatel™, LMA™, Pilling™,
QuikClot™, Rusch™, UroLift™ and Weck™ – trusted brands united by a
common sense of purpose.
Forward-Looking StatementsAny statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which
may cause actual results or company actions to differ materially
from what is expressed or implied by these statements. These risks
and uncertainties are identified and described in more detail in
our filings with the Securities and Exchange Commission, including
our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, LMA, NaviCurve,
Pilling, QuikClot, Rusch, TipTracker, UroLift, VPS Rhythm and Weck
are trademarks or registered trademarks of Teleflex Incorporated or
its affiliates, in the U.S. and/or other countries. All other marks
are the property of their respective owners. © 2023 Teleflex
Incorporated. All rights reserved. MC-009098
References:
- Data on file: D041679 Benchtop Stylet Advancement in a
Simulated Use Anatomical Model of NaviCurve™ Product Stylet/PICC
Assemblies. Bench testing may not be indicative of clinical
performance.
Rx Only
Contact:Teleflex Incorporated:Lawrence
KeuschVice President, Investor Relations and Strategy
Developmentinvestors.teleflex.com610-948-2836
Teleflex (NYSE:TFX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Teleflex (NYSE:TFX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024